Nolan Priedigkeit, MD, PhD is a medical oncologist at Dana-Farber Cancer Institute (DFCI) and Instructor of Medicine at Harvard Medical School. Clinically, he specializes in breast cancer and his research aims to merge computational and genomic sciences with technology development to make an impact on how we understand and treat metastatic disease. He received dual MD/PhD degrees from the University of Pittsburgh-Carnegie Mellon University Medical Scientist Training Program where his thesis applied translational genomics to discover novel drug targets in advanced breast cancers.
Primary Specialty
Oncologist
GenderMale
EducationUniversity of Pittsburgh School of Medicine
ServicesDana-Farber Cancer Institute provides oncology services in Boston, MA. Oncology includes the diagnosis and treatment of breast cancer, skin cancer, prostate cancer, and many other forms of cancer.
Contact Nolan Priedigkeit, MD, PhD at (877) 442-3324 for specific information about cancer treatment in Boston, MA.